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Abstract:  A  strategy  for  spectroscopy  tissue  diagnosis  using  a  small 
number of wavelengths is reported. The feasibility to accurately quantify 
tissue information using only 16 wavelengths is demonstrated with several 
wavelength reduction simulations of the existing esophageal data set. These 
results are an important step for the development of a miniaturized, robust 
and low-cost spectroscopy system. This system is based on a sub-millimeter 
high-selective  filter array  that offers prospects  for a simplified  miniature 
spectrographic detector for a future diagnostic tool to improve the diagnosis 
of dysplasia. Several thin-film optical filters are optimized and fabricated 
and its spectral performance is shown to be sufficient for the selection of 
specific wavelength bands. 
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1. Introduction 
The  majority  of  lower  esophageal  adenocarcinomas  appear  in  patients  with  Barrett's 
esophagus  (BE),  a  premalignant  condition  in  which  the  normal  squamous  epithelium  is 
replaced by metaplastic columnar epithelium. Adenocarcinomas develop through increasing 
grades of dysplasia, which is the precursor lesion of epithelial cancers. Detection of dysplasia 
is  essential  for  managing  this  type  of  cancer  since  the  chances  of  an  effective  treatment 
increase if the disease is diagnosed at an early stage, significantly improving the survival rate 
[1–4]. 
Dysplastic lesions arising in BE are difficult to identify and to diagnose using standard 
methods,  such  as  conventional  white-light  endoscopy  [5].  Therefore,  clinicians  take 
systematic patterned biopsies to screen for dysplasia. Moreover, dysplasia can be difficult to 
diagnose  due  to  the  poor  intra-  and  inter-observer  agreement  among  gastrointestinal 
pathologists [6–9]. 
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contrast based on tissue  morphology and biochemistry to help differentiate  non-dysplastic 
from dysplastic lesions in BE. These techniques can be used to guide biopsy during white-
light endoscopy [1,2,9,10]. Several groups have successfully applied diffuse reflectance and 
fluorescence spectroscopy for detecting and classifying dysplasia in BE [1,11–14]. 
Diffuse reflectance spectra can be analyzed using a well-developed analytical model to 
obtain tissue optical parameters, such as the wavelength dependent scattering parameter, and 
hemoglobin concentration and oxygen saturation [15]. Intrinsic fluorescence spectroscopy is 
used  to  extract  the  relative  contributions  of  tissue  fluorophores,  such  as  NAD(P)H  and 
collagen [16]. These parameters are subsequently correlated to histopathologic diagnosis and 
analyzed using statistical methods to develop quantitative diagnostic algorithms. 
Research  prototypes  designed  to  perform  diffuse  reflectance  and  fluorescence 
spectroscopy are generally accurate in the quantification of tissue parameters and in diagnosis. 
However, these prototypes suffer from several drawbacks. Regular optical fibers usually have 
low collection efficiency, thus requiring high quantum efficiency detectors (such as charge 
coupled device cameras - CCDs). In addition, these research prototypes (not yet commercially 
available) include costly, bulky and sophisticated illumination equipment (xenon arc lamps, 
UV lasers). Therefore, the development of a low complexity, miniature, and cost-effective 
spectroscopy system without the need of optical fibers, spectrograph or CCD cameras could 
potentially increase the collection efficiency, while simplifying the device. Previous studies 
have  aimed  to  develop  a  system  with  some  of  these  features  using  LEDs  (light-emitting 
diodes) as the illumination sources and photodiodes as the detector [17,18]. Yu et al. [17] 
developed an optical device to quantitatively assess tissue optical properties using a silicon 
photodiode for detection. However, a xenon lamp, a monochromator and optical fibers were 
still  used.  Lo  et  al.  [18]  described  a  spectroscopy  system  that  can  integrate  LEDs  for 
illumination and wavelength selection, and silicon photodiodes for detection. Even though this 
study represents a big step towards decreasing the cost and size of conventional spectroscopy 
systems, only five LED wavelengths are used, which may not be enough to accurately extract 
other  physiological  parameters  besides  hemoglobin.  The  addition  of  extra  LEDs  can 
compromise a full integration and size reduction. 
In this study we propose the development of a potentially robust sub-millimeter narrow-
band pass filter array that offers prospects for a simplified miniature spectrographic detector 
for a future spectrographic diagnostic tool to improve diagnosis of dysplasia. 
In this paper we describe a strategy for spectroscopy diagnosis using a reduced number of 
wavelengths.  The  long  term  goal  of  this  study  is  the  development  of  a  simple  spectral 
instrument based on thin-film optical filters and silicon photodiodes for signal detection. Here 
we focus on diffuse reflectance spectroscopy. Nevertheless, the instrument has potential for 
fluorescence measurements which is the subject of future work. 
2. Diffuse reflectance spectroscopy model 
In diffuse reflectance spectroscopy (DRS) white-light is delivered to the tissue and photons 
are  absorbed  and  elastically  scattered  multiple  times  by  tissue  constituents.  The  detected 
scattered photons carry information about tissue  structure and composition. Using a  well-
developed model based on the diffusion approximation [15], quantitative information about 
tissue  constituents  that  contribute  to  reflectance  can  be  extracted.  In  this  method,  the 
reflectance  spectra  are  fit  to  the  Zonios  et  al.  [15]  model  to  determine  the  values  of  the 
reduced scattering,  ' ( ) s  , and absorption,  ) ( a , coefficients of the tissue (in mm
1). These 
coefficients can be expressed as [19]: 
 
4
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' ( ) ,
B
s AC
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In  Eq.  (1),  λ  is  the  wavelength  (in  μm)  and 
0    is  equal  to  0.7  μm  (
0    is  the  reference 
wavelength for the extraction of parameter A ). The second term is used to accurately model 
reflectance at wavelengths below 0.4 μm. 
For Eq. (2)  diff C  is a correction factor to account for the vessel packaging effect (related to 
the fact that hemoglobin is restrained to blood vessels that are more or less transparent to light 
depending on the incident wavelength), and theta =  Hb c / 150 and corresponds to the volume 
fraction of blood sampled, where a hemoglobin concentration of 150 mg/mL is assumed for 
whole blood.  diff C is defined by: 
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where  r b is  the  effective  blood  vessel  radius  (in  mm)  and  ) ( 
blood
a   is  the  absorption 
coefficient of whole blood (in mm
1): 
 
2 ( ) log10.150 / . ( ) (1 ) ( ) ,
blood
a HbO Hb mg mL                (4) 
where     is  the  hemoglobin  oxygen  saturation; 
2 HbO  and  Hb    are  the  molar  extinction 
coefficient spectra of the oxygenated and deoxygenated hemoglobin, respectively. 
The measured reflectance spectra in the data set used in the present study were fit over the 
350 to 750 nm range using a nonlinear least-squares fitting algorithm. From the fitting six 
DRS parameters are extracted at each tissue spot: A, related to scatterer density (mm
1); B, 
related to the average scatterer size; C, related to scattering by small particles;  Hb c , the total 
concentration of hemoglobin (mg/mL);br  , the effective blood vessel radius (mm); and α, 
the oxygen saturation of hemoglobin. 
3. Instrumentation 
The designed system will be composed of thin-film optical filters and silicon photodiodes that 
will, respectively, select and detect several light wavelengths. In addition, commercial small-
size ultraviolet (UV) and white LEDs will be incorporated in the system as the illumination 
sources  for  fluorescence  and  diffuse  reflectance  spectroscopy,  respectively.  UV  LEDs  are 
already available at the die level (Nitride Semiconductors Co., Ltd., The Fox Group Inc., 
among others) whereas white LEDs with high luminous efficacy have already been developed 
[20].  The  use  of  these  components  eliminates  the  need  for  expensive  illumination  and 
detection equipment (high-power xenon arc lamp, CCD camera, spectrograph), and optical 
fibers to delivery and collect light from tissues. 
This miniaturized spectroscopy system could be integrated in standard clinical endoscopes 
making these instruments  more compact and portable. Its dimensional advantage can also 
enable  a  future  integration  in  a  smaller  and  less  invasive  device,  such  as  the  endoscopic 
capsule.  Once  a  CMOS  co-integration  process  is  used,  the  dimensions  of  each  optical 
microsensor (thin-film optical filter and photodiode) can be scaled down to 50x50 μm
2 to 
enable integration into an endoscopic capsule. The fabrication of the system in a compatible 
CMOS process will also allow the mass production of the microsensors at reduced costs. With 
this  integration  essential  diagnostic  functions  will  be  added  to  current  capsule  imaging 
functions.  In  this  particular  application,  numerous  microsystems  should  be  built  and 
positioned around the capsule and not only in its front (such as the cameras of the commercial 
capsules),  so  that  a  wide  tissue  area  can  be  assessed.  It  is  known  that  the  majority  of 
#144832 - $15.00 USD Received 28 Mar 2011; revised 21 May 2011; accepted 23 May 2011; pub. 25 May 2011
(C) 2011 OSA 1 June 2011 / Vol. 2,  No. 6 / BIOMEDICAL OPTICS EXPRESS  1706endoscopes that integrate spectroscopy functions use point spectroscopy instead of imaging 
spectroscopy. Despite of being a promising method for detecting early stage cancer, point 
spectroscopy  techniques  suffer  from  undersampling,  missing  contextual  information  often 
needed  to  distinguish  diseased  from  surrounding  normal  tissues.  Incorporating  optical 
detectors all around the capsule may solve this drawback. The promising developments in the 
field of the capsule locomotion and stopping mechanisms [21–23] will make it possible to 
place  the  capsule  into  gentle  contact  with  the  tissue  when  data  are  taken.  The  use  of  a 
detection system directly in contact with the tissue enables collection of most of the reemitted 
light, which represents a significant advantage over conventional systems [17,18]. Figure 1 
depicts the several components of a conventional and a miniaturized spectroscopy system. 
a) b)
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Fig. 1. Spectroscopy systems. (a) Conventional system with excitation and collection fibers, 
white-light and UV illumination sources, spectrograph and CCD for detection. (b) Miniaturized 
system with LEDs as light sources, optical filters and photodetectors for wavelength selection 
and detection, respectively (not scaled). Data transmission is intended to be wireless. 
3.1 Wavelength reduction analysis 
The possibility of replacing the spectrograph by a series of optical filters in the 350 to 750 nm 
spectral range was first investigated using an existing diffuse reflectance data set. These data 
were taken from esophageal tissue using a system described elsewhere [1]. For this study, 
simulations on wavelength reduction were performed on the data set in order to assess the 
feasibility of reducing the 400 wavelengths used to perform diagnosis to only 16, while still 
achieving  a  good  accuracy  in  the  extraction  of  tissue  optical  properties  (sixteen  was 
considered the minimum number of wavelengths from which one could accurately extract 
tissue information, as will be detailed in section 4.1). 
If that is feasible, the optical microsensors used for light collection will be composed by a 
16 narrow-band pass filter array (4 by 4), placed on top of an array of silicon photodiodes. 
The array area will be approximately 200x200 μm
2. The final encapsulation of the dies on a 
single chip will also require some space for wiring that will depend on the number of bonding 
pads (each bonding pad has a maximum size of 100x100 μm
2) and the encapsulation package. 
Each optical microsensor will be collecting different wavelength bands from slightly different 
locations in the tissue surface. However, since the maximum center to center separation of 
photodiodes  will  be  around  150  μm  it  is  reasonable  to  believe  that  no  significant  spatial 
heterogeneity will be introduced across wavelengths. Moreover, the analog photodiodes array 
readout electronics signals will be converted to digital using a compact Sigma-delta converter, 
already studied by the research group [24]. Each photodiode will have one converter. It is 
important to notice that the addition of readout electronics will not increase the size of the 
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scheme will be able to make a conversion in less than 1 microsecond. Thus, in order to avoid 
any potential spatial heterogeneity that might occur, the position of the optical array might be 
slightly  moved  to  scan  the  tissue  area  under  analysis,  enabling  several  measurements,  in 
different locations, by each optical microsensor. With this approach a matrix with 16 different 
spectral measurements in each specific location can be obtained. 
For  the  wavelength  reduction  analysis,  diffuse  reflectance  algorithms  (section  2)  were 
implemented using MATLAB tools (from The MathWorks
TM). Based on previously published 
results  [1],  several  slightly  different  combinations  of  16  wavelengths  were  chosen  and 
simulated. For all the simulations the following wavelengths were fixed: 350 and 750 nm (the 
first  and  last  wavelength  in  the  analysis);  420,  540  and  580  nm  (corresponding  to  oxy-
hemoglobin  absorption  peaks);  and  700  nm  (reference  wavelength).  The  remaining 
wavelengths were selected to cover the full visible range. The spacing between selected points 
must take into account the filters fabrication constraints, namely their FWHM (Full-Width-
Half-Maximum),  i.e.,  the  filters  transmittance  spectrum  should  not  considerably  overlap. 
Thus, the best 16 wavelengths group is composed by those 6 fixed points and by 10 more 
wavelengths  which are  more or less equally spaced along the  spectrum, corresponding to 
filters which by design don’t overlap. 
The diffuse reflectance data were then processed and data points from all wavelengths 
were eliminated, with exception for those corresponding to the selected 16 wavelengths. Thus, 
instead of  having a continuous array of 400  wavelengths (from 350 to 750 nm), and the 
corresponding reflectance intensity values, a discrete set of 16 specific data points is obtained. 
The remaining spectrum intensities are achieved by linear interpolation within the range of the 
discrete data set. This newly generated spectrum is then used to extract the tissue spectroscopy 
parameters. In the system to be developed, optical microsensors will directly provide these 16 
intensity values from which the reflectance spectrum will be reconstructed. In this procedure 
unknown data points are being calculated, and therefore one must be aware that the results 
might  not  be  exactly  the  same  as  when  using  the  original  spectrum.  Still,  the  overall 
advantages of having such a miniaturized system may offset the error. 
The feasibility study outputs the group of the 16 wavelengths that better fits the original 
continuous spectrum. These 16 wavelengths will be selectively detected using one stack of 
TiO2 and SiO2 thin-films, as detailed next below. 
3.2 Thin-film optical filters 
A  16  narrow-band  optical  filter  array  has  been  designed  based  on  Fabry-Perot  thin-film 
optical resonators. In addition to the optical filter array only a white-light and a UV source for 
reflectance and fluorescence illumination, respectively, will be required, thus avoiding a full 
spectrograph. The filtering system should be designed to yield a narrow-band pass around the 
selected wavelengths. This way, the instrument will have the high selectivity, at the desired 
wavelength, required for the application. 
The Fabry-Perot resonators consist of two flat parallel mirrors separated by a pre-defined 
distance,  with  a  resonance  cavity  in  the  middle.  The  thickness  of  the  resonance  cavity 
determines  the  transmitted  wavelength.  In  this  study,  the  mirrors  are  dielectric  mirrors 
composed of a stack of TiO2 and SiO2 thin-films (high and low refractive index materials, 
respectively, in the visible spectrum) that offer good performance characteristics with high 
reflectivity and low absorption losses [25–27]. The refractive indexes of these materials (for a 
TiO2 thickness of 52 nm and a SiO2 thickness of 95 nm) were measured by ellipsometry 
(Table  1).  Titania  and  silica  have  been  selected  because  of  the  IC  (integrated  circuit) 
compatibility and the well characterization of their deposition process. Also, the refractive 
index  of  SiO2  for  the  spectral  band  between  350  nm  and  750  nm  is  almost  wavelength 
independent (1.476 to 1.455, respectively, with variations smaller than 3%). 
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Wavelength (nm)  350  370  380  400  420  450  480  510 
n of SiO2  1.476  1.473  1.472  1.470  1.468  1.465  1.463  1.462 
n of TiO2  2.931  2.889  2.834  2.77  2.699  2.62  2.556  2.504 
Wavelength (nm)  540  560  580  600  620  650  700  750 
n of SiO2  1.460  1.459  1.459  1.458  1.458  1.457  1.456  1.455 
n of TiO2  2.461  2.434  2.411  2.39  2.375  2.351  2.318  2.294 
The selected wavelengths for this study are closely spaced. Hence, the optical filters must be 
highly selective with a FWHM less than 20 nm to avoid misidentification in the analysis by 
possible overlapping of emitted wavelengths. 
4. Results and discussion 
4.1 Wavelength reduction simulations 
The  selection  of  wavelengths  for  the  design  of  thin-film  optical  filters  was  based  on 
simulations of wavelength reduction on an existing diffuse reflectance data set. The data set 
consisted  of  53  histologically  confirmed  non-dysplastic  tissue  sites  and  10  high-grade 
dysplastic esophageal tissue sites. The goal is to investigate if it is possible to accurately 
extract  tissue  properties  using  reflectance  intensity  values  of  only  16  wavelengths,  and 
interpolating the remaining spectrum intensities to cover the whole 350 to 750 nm range. 
For  the  simulations  diffuse  reflectance  parameters  were  extracted  from  high-grade 
dysplastic and normal squamous esophageal tissue. Several combinations of 16 wavelengths 
were  simulated.  The  combination  that  provided  the  best  results  comprises  the  following 
discrete points: 350, 370, 380, 400, 420, 450, 480, 510, 540, 560, 580, 600, 620, 650, 700, and 
750 nm. For this  wavelength selection a compromise between the accuracy in parameters 
extraction and the constraints inherent to the filters fabrication process (e.g. materials, number 
of layers, FWHM, and maximum transmission) had to be achieved. This wavelength choice is 
important for the intended diagnosis and will be dependent on the clinical situation for which 
the system is going to be used for. Since the esophagus is expected as the first application of 
the microsystem, the used clinical data set is suitable for the simulations. Examples of DRS 
spectra of high-grade dysplasia and non-dysplastic squamous tissue are shown in Fig. 2. 
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Fig.  2.  Examples  of  DRS  spectra  for  normal  (upper  line)  and high-grade  dysplastic  tissue 
(bottom line), for (a) the full wavelength range (original spectrum) (b) and only 16 wavelengths 
(reconstructed spectrum). 
The  reduced  scattering  and  absorption  coefficients  were  determined  for  16  different 
wavelengths,  using  the  original  spectrum  and  the  reconstructed  spectrum  of  high-grade 
dysplastic and non-dysplastic tissue sites (Fig. 3). In general, the extracted coefficients using 
the reconstructed spectrum are in good agreement with the coefficients extracted from the 
original spectrum, with a strong and positive correlation: correlation coefficients of 0.951 and 
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sites, respectively; and, 0.966 and 0.987 for the absorption coefficient of high-grade dysplasia 
and non-dysplastic tissue sites, in that order. Thus, it is expected that the miniaturized system 
and the conventional systems will have very comparable performance in the quantification of 
tissue optical information. 
a) b)  
Fig. 3. Scatter plots with the (a) reduced scattering coefficient and (b) absorption coefficient, 
determined for several different wavelengths: 350, 370, 380, 400, 420, 450, 480, 510, 540, 560, 
580, 600, 620, 650, 700, and 750 nm. For each of these wavelengths, a different coefficient will 
be determined in each tissue site: a total of 10 high-grade dysplastic tissue sites and 53 non-
dysplastic tissue sites were used, corresponding to 160 (10 times 16) and 848 (53 times 16) 
different values of reduced scattering and absorption coefficient. Y-axis represents the values 
of the coefficients extracted with the original spectrum; X-axis represents the values of the 
coefficients determined with the reconstructed spectrum, using only 16 points. The 45 degree 
black  line  represents  a  perfect  agreement  between  the  expected  values,  from  the  original 
spectrum, and the extracted values, from the reconstructed spectrum. 
An even more reduced number of wavelengths for spectra analysis would be useful to 
further  reduce  the  size  and  complexity  of  the  optical  microsensors.  However  a  trade-off 
between this number and an accurate extraction of optical parameters had to be achieved. 
Sixteen  was  considered  the  limit  beyond  which  one  could  accurately  determine  those 
parameters. 
For demonstration, Fig. 4 presents the same results of Fig. 3 but extracted using only 10 
wavelengths (350, 380, 400, 420, 480, 540, 580, 600, 700 and 750), instead of 16. In this 
approach, the extracted coefficients using the reconstructed spectrum have weaker correlations 
with  the  coefficients  determined  from  the  original  spectrum,  when  compared  with  the 
previous strategy. Specifically, for the reduced scattering coefficient of non-dysplastic tissue 
sites, there is a weak and not very significant correlation between the expected and extracted 
values,  with  a  correlation  coefficient  of  0.326.  From  the  obtained  results  it  is  clear  the 
performance improvement of using 16 over 10 wavelengths for quantitative spectroscopy. 
The theoretical parameters extraction performance of the miniaturized system was then 
assessed. Scatter plots displaying the expected (using the full spectrum) and extracted (using 
only 16 wavelengths) parameter values are presented in Fig. 5 for four DRS parameters: two 
parameters extracted from the reduced scattering coefficient (A and B), and two parameters 
extracted from the absorption coefficient ( Hb c  and  r b ). 
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Fig. 4. Scatter plots with the (a) reduced scattering coefficient and (b) absorption coefficient, 
determined for several different wavelengths: 350, 370, 380, 400, 420, 450, 480, 510, 540, 560, 
580, 600, 620, 650, 700, and 750 nm. Y-axis represents the values of the coefficients extracted 
with the original spectrum; X-axis represents the values of the coefficients determined with the 
reconstructed spectrum, using only 10 points. 
 
Fig. 5. Scatter plots with the tissue parameter values for four DRS parameters:  A, B,  Hb c  
(hemoglobin concentration), and  br   (effective blood vessel radius), extracted using the full 
spectrum (expected values) and only 16 wavelengths (extracted values). 
Overall,  the  reported  results  demonstrate  that  reflectance  tissue  parameters  can  be 
relatively well determined using a reduced number of wavelengths, and thus these parameters 
can be used with confidence for the development of predictive models to identify normal and 
malignant  tissues.  Still,  for  some  tissue  sites,  optical  parameters  could  not  be  accurately 
extracted, which might be due to loss of spectral information with interpolation. The use of a 
different interpolation method could minimize this error. Also, in further studies an alternative 
approach will be evaluated: a model discretization will be applied and the parameter results 
will be compared to the ones obtained using linear interpolation. 
This  rough  methodology  is  applied  as  an  initial  approach  to  select  the  16  central 
wavelengths to fabricate the optical filters, and to demonstrate the feasibility of wavelength 
reduction for the assessment of tissue optical properties. 
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The obtained results show the viability of using 16 wavelengths to extract tissue biochemical 
and morphological information. The selection of these wavelengths can be achieved using a 
16 narrow-band pass optical filter array. This array is composed of three groups of optical 
filters to cover different regions of the spectrum: near-UV/violet (350 to 450 nm); red (620 to 
750 nm); central band of the visible spectrum (480 to 600 nm). Thin-film optics software 
TFCalc
TM 3.5 was used for the structural optimization of the optical filters. Simulations were 
performed using the previously measured refractive indexes (Table 1). In each group, the 
filters are composed by 11 layers of TiO2 and SiO2, and can be easily tuned to a different 
wavelength by adjusting the thickness of the resonance cavity, e.g., the 6th layer (Table 2). 
This enables the fabrication of several optical filters in each region of the spectrum while 
minimizing the global deposition time. 
Table 2. Layer Thicknesses of the 16 Fabry-Perot Optical Filters 
  Maximum wavelength transmission 
  350  370  380  400  420  450  480  510  540  560  580  600  620  650  700  750 
  Layer thicknesses (nm) 
TiO2  36  52  72 
SiO2  68  95  116 
TiO2  36  52  72 
SiO2  68  95  116 
TiO2  36  52  72 
SiO2  94  110  120  136  154  182  140  164  192  206  227  242  182  210  255  301 
TiO2  36  52  72 
SiO2  68  95  116 
TiO2  36  52  72 
SiO2  68  95  116 
TiO2  36  52  72 
Meanwhile, 6 of the 16 optical filters were fabricated in order to adjust the manufacturing 
process  before  proceeding  with  the  fabrication  of  the  remaining  filters.  Thin-film  optical 
filters fabrication needs to be well controlled and optimized, because the position of the peak 
is highly sensitive to thickness variation. For example, a thickness variation of only 1 nm in 
each of the TiO2 layers, relative to what was initially designed, is enough to move the peak to 
a different central wavelength. As demonstrated in Fig. 6, an increase of 1 nm in the thickness 
of each of the TiO2 layers significantly affects the central peak position of the 540 nm filter 
(this effect might be noticed not only in the peak central wavelength, but also in its FWHM 
and  transmission  efficiency).  For  that  reason,  the  filters  were  deposited  by  Ion  Beam 
Deposition (IBD) in a 1 nanometer resolution system (Nordiko 3000). 
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Fig. 6. Simulated spectral transmittance for the 540 nm optical filter, with maximum intensity 
peaks at: (a) 540 and (b) 543 nm, when there is an increase of 1 nm in the thickness of each of 
the TiO2 layers. 
Prior to filters fabrication, simple SiO2 and TiO2 films were deposited on silicon substrates 
to calibrate deposition rates and indexes of refraction. Subsequently, multilayer filters were 
deposited on a glass substrate. 
#144832 - $15.00 USD Received 28 Mar 2011; revised 21 May 2011; accepted 23 May 2011; pub. 25 May 2011
(C) 2011 OSA 1 June 2011 / Vol. 2,  No. 6 / BIOMEDICAL OPTICS EXPRESS  1712The fabricated narrow-band pass filters were analyzed by cross section SEM (Scanning 
Electron Microscope) in order to assess layer thicknesses and interface quality between the 
SiO2 and TiO2 layers. Figure 7 depicts the cross-section of one of the analyzed optical filters 
(filter with peak centered at 560 nm). 
 
Fig. 7. SEM photograph showing the cross-section of the Fabry-Perot optical filter with the 
peak centered at 560 nm (magnification 200,000 times). 
Figure 7 demonstrates the clear separation between the SiO2 and TiO2 layers, with very 
low interface mixing (brighter layers correspond to TiO2). The mirrors thicknesses are in good 
agreement with the outlined values, whereas the resonance cavity thickness is slightly lower 
than what was initially designed (206 nm). Very good film flatness is shown along the entire 
area. This feature allows guarantee the parallelism of the mirrors concerning to the resonance 
cavity, which is crucial for reproducible optical measurements. 
The transmittance of the fabricated filters was then assessed using a spectrophotometer 
from Shimadzu (UV-3101PC), and is demonstrated in  Fig. 8. All the  measurements  were 
performed with the placement of a wide-band pass filter (200 nm wide) on top of the optical 
filters. This wide-band pass filter eliminates the tails of the filters outside the 450-650 nm 
spectral region. At this stage, this filter was fabricated on a glass substrate and placed on top 
of the 6 Fabry-Perot optical filters. In the final device, a thin-film wide-band pass filter will be 
processed  directly  on  top  of  the  narrow-band  optical  filters  array,  and  its  effect  will  be 
combined in the measurements with the optical effect of the silicon photodiodes. A wide-band 
pass filter is easily obtained with a multilayer structure, composed by 11 layers of SiO2 and 
TiO2,  which  can  be  represented  by:  SiO2/TiO2/  SiO2/TiO2/  SiO2/TiO2/  SiO2/TiO2/ 
SiO2/TiO2/SiO2. All these layers have a thickness equal to 88 nm. 
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Fig. 8. Measured transmittance spectra for the 6 fabricated Fabry-Perot optical filters with the 
wide-band pass filter included. 
Optical  spectra  measurements  show  that  a  multilayer  structure  composed  of 
(TiO2,SiO2)
2TiO2/SiO2/TiO2(SiO2,TiO2)
2 is the best option in terms of optical characteristics 
and fabrication process. The results show that each filter is sensitive to a specific spectral 
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greater than 70/20. The FWHM translates the quality of the filter in terms of its ability to 
select a narrow band of the electromagnetic spectrum, and therefore, ideally, should be as low 
as  possible.  Additionally,  the  transmittance  peak  should  be  high,  with  at  least  twice  the 
intensity of any background noise that might appear in the considered spectral range, so that 
we can clearly discriminate the specific wavelengths, without noise overlap (if it is less, the 
background  noise  will  significantly  affect  the  measurements)  [25].  The  filters  peaks  are 
slightly deviated from what was designed, being centered at: 478; 510; 540; 558; 574; and 598 
nm. These differences between the design and the outcome of the fabrication process are 
mainly explained by the etching that might occur in some of the layers immediately below, 
when the multilayer is deposited. Indeed, the total thickness of the multilayers was measured 
using a profilometer, and the result was 2% less than what was initially designed. This event 
will obviously shift the central transmitted wavelength. As mentioned before, the process is 
being  optimized  and  adjustments  on  the  deposition  rates  are  on-going.  The  overall 
performance of the optical filters could be improved by increasing the number of dielectric 
layers, but the fabrication process complexity would also increase. 
The integration of optical  filters, photodiodes and readout electronics on a single-chip 
requires the system to fit in a microelectronic process, preferably CMOS. The CMOS process 
provides  three  photosensitive  structures  as  vertical  junction  photodiodes.  At  a  particular 
wavelength,  their  quantum  efficiency  varies  according  to  their  junction  depth.  For  this 
particular spectral region, we will use pn-junction photodiodes fabricated in a standard 0.7 μm 
CMOS process, without additional masks or steps. 
As  an  example,  a  simulation  of  the  optical  transmittance  for  the  540  nm  filter  was 
performed taking into account the effect of the previously described wide-band pass filter and 
the effect of using a n + /p-epilayer photodiode to read the signal. Previous studies from our 
group have shown the fabrication and characterization of this type of photodiode [28]. The 
thickness  of  the  photodiode  junction  depth  is  fixed  by  the  microelectronics  foundry,  and 
equals to 350 nm (this junction depth is included in the simulations). Figure 9(a) depicts the 
transmittance  of  the  filter  without  the  optical  effect  of  the  wide-band  pass  filter  and 
photodiode, whereas Fig. 9(b) illustrates the transmittance of the narrow-band pass filter with 
both effects included in the simulation. From Fig. 9(b) it is clear the signal attenuation below 
450 nm and after 650 nm to less than 12%. Also, the maximum transmittance is lower due to 
the effect of the wide-band pass filter and photodiode. This approach enables the collection of 
spectroscopy data only around the filter central wavelength. 
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Fig.  9.  Simulated  transmittance  spectra  for  the  540  nm  Fabry-Perot  optical  filter:  (a)  not 
including and (b) including the optical effect of the wide-band pass filter and the  n + /p-
epilayer photodiode. 
A new study was carried out for assessing the performance of the fabricated optical filters 
when used for spectroscopy. This study consisted in measuring diffuse reflectance spectrum 
from a tissue phantom using the fabricated optical filters (together with the wide-band pass 
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accurately each filter could detect the diffuse reflectance signal. The phantoms consist of a 
mixture of intralipid and hemoglobin (Sigma Aldrich Co.) and water. The intralipid and the 
water soluble hemoglobin are used for scattering and absorbing, respectively. All the collected 
spectra were normalized by the reflectance spectra measured from a standard (solid sample of 
BaSO4) to correct for the wavelength dependent response of the system. 
For this study, a diffuse reflectance spectrum measured from the tissue phantom without 
using  optical  filters  was  first  acquired  (Fig.  10(a)).  After,  consecutive  diffuse  reflectance 
measurements  using  each  of  the  fabricated  filters  in  front  of  the  detection  system  were 
performed  on  the  same  tissue  phantom  (Fig.  10(b)).  The  resulting  6  Gaussian  distributed 
spectra  were  integrated  over  the  full  wavelength  range.  The  obtained  6  intensity  values 
correspond to the signal that will be read by the optical microsensor. In a further processing, 
the filters transmittance spectra (Fig. 8) were also integrated, and the intensity read by the 
optical microsensor was divided by these 6 values. This way, one can obtain the final 6 data 
points that will compose the wavelength-reduced spectrum (Fig. 10(c)). 
The  intensity  values  obtained  with  the  fabricated  filters  are  similar  to  the  originally 
obtained reflectance intensities measured over the full wavelength range, except for the 540 
and 580 nm valleys that are not as noticeable as desired. This divergence might be explained 
by the filters FWHM. The on-going optimizations to the fabrication process should enable the 
fabrication of more accurate filters, correctly centered at the specific wavelengths, and with a 
smaller FWHM. Overall, it is reasonable to consider that the results validate the possibility of 
replacing the spectrograph by an array of thin-film narrow-band pass filters. 
0.00
0.05
0.10
0.15
0.20
0.25
0.30
350 450 550 650 750
I
n
t
e
n
s
i
t
y
 
(
a
.
u
.
)
Wavelength (nm)
0.00
0.05
0.10
0.15
0.20
0.25
0.30
350 450 550 650 750
I
n
t
e
n
s
i
t
y
 
(
a
.
u
.
)
Wavelength (nm)
a) b)
c)
0.00
0.05
0.10
0.15
0.20
0.25
0.30
350 450 550 650 750
I
n
t
e
n
s
i
t
y
 
(
a
.
u
.
)
Wavelength (nm)
140
164
192
206
227
242
Resonance 
cavity 
thicknesses
(in nm)
 
Fig. 10. Diffuse reflectance spectra: (a) measured with the UV-3101PC spectrophotometer; (b) 
measured with the 6 fabricated narrow-band pass optical filters; and, (c) together with the 6 
integrated intensity values that will be obtained using the miniaturized system. 
5. Conclusions 
Diffuse  reflectance  spectroscopy  is  used  to  analyze  tissue  and  to  extract  quantitative 
information. This study demonstrates that it is possible to obtain tissue properties accurately 
using a small number of wavelengths. These results represent an important step towards the 
development  of  a  much  smaller,  simpler,  and  cost-effective  device  compared  with  the 
conventional spectroscopy prototypes, and with similar throughput. 
The wavelength-reduction simulations were performed using real esophageal tissue data 
and the values of tissue properties obtained with the selected 16 wavelengths are comparable 
with those obtained using 400 wavelengths. However, it is important to notice the significance 
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After this feasibility study, thin-film narrow-band pass filters were fabricated and its optical 
performance was assessed. Reflectance measurements, performed on tissue phantoms, using 
the full wavelength range and the fabricated optical filters provided comparable results. 
Overall, the results show the feasibility of replacing the spectrograph in a conventional 
system by a series of narrow-band pass optical filters in the new spectroscopy system. Also, 
with a future integration of LEDs for illumination and silicon photodiodes for detection, the 
instrument  will  be  fully  miniaturized  while  still  providing  similar  results  in  terms  of 
quantitative  diagnostic  information.  The  described  results  open  the  way  to  explore  the 
integration of the developed instrument into endoscopic devices with clinical potential. Due to 
its reduced size, it could be incorporated in standard endoscopes making it more compact and 
portable. Moreover, it has a potential to be integrated, in the future, into smaller, less-invasive 
devices, such as the endoscopic capsules. The future directions include: filter optimization 
(specified band pass, FWHM, signal-to-noise ratio, and reliable reproducibility); assembling 
the 16 filters with the silicon photodiodes (in a 4 by 4 array), on a single-chip with readout 
electronics; accommodate on the same chip UV and white-light miniaturized sources. 
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